Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
PANACEABIO

Panacea Biotec Share Price

 

 

Panacea Biotec live price: ₹418.35. It opened at ₹413 vs previous close ₹416; intraday high/low: ₹424/₹401. The 50 & 200 DMA stand at ₹365.37/₹373.70.

Panacea Biotec Performance

  • Today's Low
  • ₹401
  • Today's High
  • ₹424
  • 52 Week Low
  • ₹292
  • 52 Week High
  • ₹550
  • Open Price₹413
  • Previous Close₹416
  • Volume155,095
  • 50 DMA₹365.37
  • 100 DMA₹364.89
  • 200 DMA₹373.70

Panacea Biotec Chart

Investment Returns

  • Over 1 Month + 16.61%
  • Over 3 Month + 20.91%
  • Over 6 Month + 12.96%
  • Over 1 Year -21.3%

Smart Investing Starts Here Start SIP with Panacea Biotec for Steady Growth!

Invest Now

Panacea Biotec Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -329.4
  • PEG Ratio
  • -200.4
  • Market Cap Cr
  • 2,562
  • P/B Ratio
  • 3.1
  • Average True Range
  • 21.1
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • 13.3
  • RSI
  • 65.43
  • MFI
  • 77.53

Latest Stock News Updates

Q3FY26 Quarterly Result Announced for Panacea Biotec Ltd.

Biotechnology company Panacea Biotec announced Q3FY26 results Revenue: Rs 16,519 lakh against Rs 16,349 lakh during Q3FY25, change 1%. PBT: Rs 649 lakh against Rs 438 lakh during Q3FY25, change 48%. PAT: Rs 389 lakh against Rs 444 lakh during Q3FY25, change -12%. EPS: Rs 0.65 for Q3FY26. Result PDF

Panacea Bio share price surges 6% after completing enrollment of study participants for Dengiall Phase-III trial

Panacea Bio share price has gained 7.27% in the past five sessions and nearly 21% in a month. However, the scrip has declined by over 11% a year.

SGS Expands Digital Trust Leadership with Acquisition of Panacea Infosec in India

Panacea Biotec Financials

Panacea Biotec Technicals

EMA & SMA

Current Price
₹418.35
+ 1.95 (0.47%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹383.05
  • 50 Day
  • ₹365.37
  • 100 Day
  • ₹364.89
  • 200 Day
  • ₹373.70

Resistance and Support

414.35 Pivot Speed
  • R3 450.25
  • R2 436.95
  • R1 427.65
  • S1 405.05
  • S2 391.75
  • S3 382.45

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Panacea Biotec is a biotechnology company specializing in research, development, and manufacturing of vaccines, pharmaceuticals, and biosimilars. It operates state-of-the-art facilities in India, serving global markets across North America, Europe, and emerging economies.

Panacea Biotec (Nse) has an operating revenue of Rs. 605.55 Cr. on a trailing 12-month basis. An annual revenue de-growth of -1% needs improvement, Pre-tax margin of -1% needs improvement, ROE of -1% is poor and needs improvement. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 16% and 6% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 14 which is a POOR score indicating inconsistency in earnings, a RS Rating of 70 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 49 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Panacea Biotec Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-11 Quarterly Results
2025-11-14 Quarterly Results
2025-08-14 Quarterly Results
2025-05-30 Audited Results & Dividend
2025-02-14 Quarterly Results

Panacea Biotec Shareholding Pattern

72.48%
0%
1.6%
16.81%
9.11%

Panacea Biotec FAQs

Panacea Biotec share price is ₹418 As on 20 May, 2026 | 20:16

The Market Cap of Panacea Biotec is ₹2562.4 Cr As on 20 May, 2026 | 20:16

The P/E ratio of Panacea Biotec is -329.4 As on 20 May, 2026 | 20:16

The PB ratio of Panacea Biotec is 3.1 As on 20 May, 2026 | 20:16

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23